BioXcel LLC - 25 Jun 2021 Form 4 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Role
10%+ Owner
Signature
/s/ Krishnan Nandabalan, President
Issuer symbol
BTAI
Transactions as of
25 Jun 2021
Net transactions value
-$14,589,493
Form type
4
Filing time
29 Jun 2021, 17:22:44 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTAI Common Stock Sale $14,589,493 -473,250 -5.2% $30.83 8,546,750 25 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 25, 2021, the Reporting Person sold 473,250 shares of common stock of the Issuer as a selling stockholder in an underwritten public secondary offering at a price to the public of $31.70 per share . The reported sale price reflects the price at which the Reporting Person sold shares to the underwriters after underwriting discounts and commissions.